+1 (202) 780-3397
Rapid Communication - Current Trends in Cardiology (2024) Volume 8, Issue 1
The developmental origins of the normal left ventricular myocardium
Juan Guo *
Department of Nursing, Suzhou Hospital of Anhui Medical University China.
- *Corresponding Author:
- Juan Guo
Department of Nursing
Suzhou Hospital of Anhui Medical University
China
E-mail: GuoJuan567@gmail.com
Received:26-Dec-2023,Manuscript No. AACC-24-130259; Editor assigned:29-Dec-2024,PreQC No. AACC-24-130259(PQ); Reviewed:12-Jan-2024,QC No. AACC-24-130259; Revised:17-Jan-2024, Manuscript No. AACC-24-130259(R); Published:23-Jan-2024,DOI:10.35841/aacc-8.1.242
Citation: Guo J. The developmental origins of the normal left ventricular myocardium. Curr Trend Cardiol. 2024;8(1):242.
Introduction
The human heart is a marvel of biological engineering, orchestrating the rhythmic flow of blood throughout our bodies from the earliest stages of development until our last breath. Central to its function is the left ventricle, which pumps oxygenated blood to the entire body. Understanding the origins of the normal left ventricular myocardium is a crucial step in unraveling the mysteries of heart development and function. In this article, we delve into the developmental origins of the left ventricular myocardium, exploring how this vital structure forms and matures.The development of the left ventricular myocardium begins in the embryonic stage. Around the third week of gestation, the heart tube forms from the lateral folding of the embryonic disc. This tube undergoes a complex series of morphological changes to give rise to the mature heart, including the formation of the left ventricle. The heart tube consists of two layers: an outer myocardial layer and an inner endocardial layer [1,2].
Early in development, the heart tube starts to loop, ultimately positioning the future left ventricle on the left side of the heart. This looping is a critical step in establishing the left-right axis of the heart. As the looping progresses, a region within the heart tube begins to expand and thicken, forming the primordial left ventricle.The left ventricular myocardium is composed primarily of cardiomyocytes, the specialized muscle cells responsible for the heart's contractile function. Cardiomyocytes differentiate from mesodermal cells during embryonic development. Key signaling pathways, such as the bone morphogenetic protein (BMP) and fibroblast growth factor (FGF) pathways, play pivotal roles in cardiomyocyte differentiation.During early cardiac development, a population of progenitor cells known as the cardiac crescent arises from the mesoderm. These progenitor cells give rise to various cardiac structures, including the left ventricular myocardium. As development proceeds, these progenitor cells undergo differentiation into mature cardiomyocytes under the influence of various signaling molecules and transcription factors. Some of the critical transcription factors involved in this process include [3,4].
In addition to cardiomyocytes, the left ventricular myocardium contains other essential components, such as the extracellular matrix and cardiac cushions. The cardiac jelly is a gel-like substance rich in glycosaminoglycans and proteoglycans that fills the space between the myocardial and endocardial layers. It plays a crucial role in maintaining the structural integrity of the developing heart and facilitating the movement of cells during cardiac morphogenesis.The cardiac cushions, also known as endocardial cushions, form within the heart tube and contribute to the separation of the atria from the ventricles. These cushions are composed of specialized endocardial cells and extracellular matrix components. Their formation is tightly regulated by signaling pathways like the transforming growth factor-beta (TGF-β) pathway. Disruptions in cardiac cushion formation can lead to congenital heart defects, highlighting their importance in the development of the left ventricular myocardium. [5,6].
The left ventricular myocardium continues to undergo significant changes after its initial formation. One of the key processes during myocardial maturation is cardiomyocyte proliferation and hypertrophy. In the early stages of development, cardiomyocytes actively divide to increase the myocardial mass. However, this proliferative capacity decreases shortly before birth, and most cardiomyocyte growth occurs through hypertrophy, where individual cells increase in size. [7,8].
Another critical aspect of myocardial maturation is the establishment of a functional network of blood vessels, ensuring that the myocardium receives an adequate blood supply. The coronary arteries, which provide oxygen and nutrients to the myocardium, start to develop during embryonic stages and become fully functional after birth. The left ventricular myocardium also undergoes structural changes, including the alignment of cardiomyocytes in a coordinated manner to optimize the efficiency of contraction. This alignment, along with the development of intercalated discs, allows for synchronized electrical conduction between cardiomyocytes, facilitating the heart's pumping action. [9,10].
Conclusion
The development of the left ventricular myocardium is a complex and highly orchestrated process that begins in the embryonic stages and continues throughout fetal and postnatal life. It involves the differentiation of cardiomyocytes, the formation of the cardiac jelly and cardiac cushions, and the maturation of the myocardium's structure and function. Understanding the developmental origins of the normal left ventricular myocardium is not only of great scientific interest but also has clinical implications. Congenital heart defects often result from disruptions in these developmental processes, underscoring the importance of this research for diagnosing and treating cardiac disorders. As our knowledge of cardiac development advances, it brings us closer to unraveling the intricacies of the heart's formation and function. This knowledge may one day lead to new therapies and interventions that can improve the lives of individuals affected by heart-related conditions, ultimately advancing the field of cardiovascular medicine.
References
- Delcroix M, Kerr K, Fedullo P. Chronic thromboembolic pulmonary hypertension. Epidemiology and risk factors.Ann Am Thorac Soc.2016;13(3):S201–S206.
- Goldhaber SZ, Hennekens CH, Evans DA, et al. Factors associated with correct antemortem diagnosis of major pulmonary embolism.Am J Med.1982;73(6):822-826.
- Goldhaber SZ, Grodstein F, Stampfer MJ, et al. A prospective study of risk factors for pulmonary embolism in women.JAMA.1997;277(8):642-645.
- Caforio ALP., Pankuweit S., Arbustini E., et al. Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases. Eur Heart J. 2013;34(33):2636-648.
- Smith SB, Geske JB, Kathuria P, et al. Analysis of national trends in admissions for pulmonary embolism.Chest.2016;150(1):35-45.
- Sischo L, Broder H. Oral health-related quality of life: what, why, how, and future implicationsJ Den Res.2011;90(11):1264-70.
- Charnock-Jones DS, Kaufmann P, Mayhew TM.Aspects of human fetoplacental vasculogenesis and angiogenesis. I. Molecular regulation. Placenta.2004;25(2-3):103-13.
- Wolk MJ, Bairey Merz CN, Thompson PD.President's page: The promise of prevention: So, why aren'tall cardiologists “preventive”?. J Am Coll Cardiol .2004;44(10):2082-4.
- Newton MJ.Precedent autonomy: Life-sustaining intervention and the demented patient.Camb Q Healthc Ethics.1999;8(2):189-99.
- Jain D, Maleszewski JJ, Halushka MK. Benign cardiac tumors and tumor like conditions.Ann Diagn Pathol.2010;14:215–230.
Indexed at, Google Scholar, Crossref
Indexed at, Google Scholar, Crossref
Indexed at, Google Scholar, Cross Ref
Indexed at, Google Scholar, Crossref
Indexed at, Google Scholar, CrossRef
Indexed at, Google Scholar, CrossRef
Indexed at,Google Scholar, CrossRef
Indexed at, Google Scholar, CrossRef